ReviewSemin Cancer Biol2022
Regulation of pancreatic cancer therapy resistance by chemokines.
- Journal
- Semin Cancer Biol
- Published
- 2 September 2022
- Citations
- 19
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 7
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Targeted Radiation Therapy for Pancreatic Cancer R01CA195586↗
- Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer R01CA247471↗
- MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases R44DK117472↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗
- Pancreatic Cancer Detection Consortium U01CA210240↗
- Nanovaccine platforms to combat pancreatic cancer U01CA213862↗